Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001999714 | SCV002232683 | pathogenic | Familial hypercholesterolemia | 2021-11-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp6*) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This premature translational stop signal has been observed in individual(s) with familial hypercholesterolemia (PMID: 28964736, 32041611, 33303402). This variant is not present in population databases (gnomAD no frequency). |